Zhejiang Hisun Pharmaceutical Co.,Ltd.

About Zhejiang Hisun Pharmaceutical Co.,Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang Province, a coastal city in southeastern China, was founded in 1956. In year 2000, Hisun was listed as a public company in Shanghai A share Stock Exchange. We are the largest antibiotics, anticancer drugs production supplier. We provide diverse products and services. Our research channels cover many indications extensively: like anticancer, cardiovascular, anti-infective, anti-parasitics, immunosuppressant, etc.

  • CN
  • 2015
    On CPHI since
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from Zhejiang Hisun Pharmaceutical Co.,Ltd. (41)

  • Orlistat

    Product Orlistat

    OTC weight-reducing drug , DMF available
  • Celecoxib

    Product Celecoxib

    API for bone & Jolt health, DMF available 
  • Acarbose

    Product Acarbose

    Antidiabetic Agents, DMF approved, CEP approved
  • Tigecycline

    Product Tigecycline

    Anti-infective API, DMF available
  • Tazobatactam

    Product Tazobatactam

    Anti-infective API, DMF aprroved
  • Meropenem

    Product Meropenem

    Anti-infective API, DMF available
  • Isepamicin Sulfate

    Product Isepamicin Sulfate

    Anti-infective API, DMF available
  • Daptomycin

    Product Daptomycin

    Anti-infective API, DMF approved
  • Simvastatin

    Product Simvastatin

    Cardiovascular API, DMF available, CEP approved
  • Pravastatin Sodium

    Product Pravastatin Sodium

    Cardiovascular API,  DMF available, CEP approved
  • Lovastatin

    Product Lovastatin

    Cardiovascular API, DMF available, CEP approved
  • Atorvastatin Calcium

    Product Atorvastatin Calcium

    Cardiovascular API, DMF available, CEP approved